These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26473290)

  • 21. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular studies of Varicella zoster virus.
    Quinlivan M; Breuer J
    Rev Med Virol; 2006; 16(4):225-50. PubMed ID: 16791838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
    Kohlmann R; Salmen A; Chan A; Knabbe C; Diekmann J; Brockmeyer N; Skaletz-Rorowski A; Michalik C; Gold R; Überla K
    Mult Scler; 2015 Dec; 21(14):1823-32. PubMed ID: 25828755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the treatment of varicella-zoster virus infections.
    Andrei G; Snoeck R
    Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Meningitis associated with reactivation of varicella-zoster virus].
    Mørch K; Fylkesnes SI; Haukenes G
    Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2871-3. PubMed ID: 14600712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of varicella-zoster virus (VZV) immediate-early ORF62 transcription by VZV ORF63 correlates with virus replication in vitro and with latency.
    Hoover SE; Cohrs RJ; Rangel ZG; Gilden DH; Munson P; Cohen JI
    J Virol; 2006 Apr; 80(7):3459-68. PubMed ID: 16537613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion in open reading frame 49 of varicella-zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts.
    Sadaoka T; Yoshii H; Imazawa T; Yamanishi K; Mori Y
    J Virol; 2007 Nov; 81(22):12654-65. PubMed ID: 17855513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The varicella-zoster virus-mediated delayed host shutoff: open reading frame 17 has no major function, whereas immediate-early 63 protein represses heterologous gene expression.
    Desloges N; Rahaus M; Wolff MH
    Microbes Infect; 2005 Dec; 7(15):1519-29. PubMed ID: 16039898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
    van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
    J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.
    Palumbo PE; Arvin AM; Koropchak CM; Wittek AE
    J Gen Virol; 1984 Dec; 65 ( Pt 12)():2141-7. PubMed ID: 6096492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human ocular-derived virus-specific CD4+ T cells control varicella zoster virus replication in human retinal pigment epithelial cells.
    Milikan JC; Baarsma GS; Kuijpers RW; Osterhaus AD; Verjans GM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):743-51. PubMed ID: 18936136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters.
    El Mjiyad N; Bontems S; Gloire G; Horion J; Vandevenne P; Dejardin E; Piette J; Sadzot-Delvaux C
    J Virol; 2007 Dec; 81(23):13092-104. PubMed ID: 17855547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into the function of tegument proteins from the varicella zoster virus.
    Wang W; Cheng T; Zhu H; Xia N
    Sci China Life Sci; 2015 Aug; 58(8):739-49. PubMed ID: 26208824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of cellular transcription factors in VZV replication.
    Ruyechan WT
    Curr Top Microbiol Immunol; 2010; 342():43-65. PubMed ID: 20490778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varicella-zoster virus latency in human ganglia.
    Kennedy PG
    Rev Med Virol; 2002; 12(5):327-34. PubMed ID: 12211045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varicella-zoster virus-specific cell-mediated immune responses in HIV-infected adults.
    De Castro N; Carmagnat M; Kernéis S; Scieux C; Rabian C; Molina JM
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1089-97. PubMed ID: 21417759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Immunosenescence on Viral Infections with an Emphasis on COVID-19.
    Murdaca G; Paladin F; Martino G; Gangemi S
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):225. PubMed ID: 37796718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular Senescence, Immunosenescence and HIV.
    Fülöp T; Herbein G; Cossarizza A; Witkowski JM; Frost E; Dupuis G; Pawelec G; Larbi A
    Interdiscip Top Gerontol Geriatr; 2017; 42():28-46. PubMed ID: 27875822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in RNA Polymerase III genes and defective DNA sensing in adults with varicella-zoster virus CNS infection.
    Carter-Timofte ME; Hansen AF; Christiansen M; Paludan SR; Mogensen TH
    Genes Immun; 2019 Mar; 20(3):214-223. PubMed ID: 29728610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.